imugene (asx:imu) talks phase 1 & 2 cancer trials
Published 6 years ago • 736 plays • Length 6:03Download video MP4
Download video MP3
Similar videos
-
5:27
imugene (asx:imu) targeting gastric cancer
-
4:14
imugene (asx:imu) doses first patient in iv arm of phase 1 oncarlytics trial targeting solid cancers
-
4:29
imugene (asx:imu) targeting gastric cancer
-
4:24
imugene (asx:imu) 1h18 results & outlook
-
5:05
arovella therapeutics (asx:ala) partners with imugene (asx:imu)
-
9:34
imugene (asx: imu) – first patient dosed in checkvacc phase 1 trials
-
4:44
immutep (asx:imm) - innovative cancer therapies
-
20:37
imugene (asx: imu) – the ‘holy grail’ of cancer treatment…?! | asx ceo interview 🚀📈
-
13:15
imugene ltd (asx:imu) investor presentation 2017
-
0:43
how imugene (asx: imu) is changing the lives of cancer patients #shorts
-
4:49
imugene her-vaxx video asx: imu | an emerging leader in cancer immuno-oncology
-
4:11
imugene limited (asx: imu) | snn network
-
26:23
imugene (asx:imu) presentation, nwr virtual healthcare conference
-
6:40
imugene doses first patient in vaxinia phase 1 trial
-
20:57
imugene (asx: imu) - discussing imu's 2022 biotech opportunity
-
7:40
imugene limited (asx: imu) emergence 2024: presentation by leslie chong, managing director and ceo
-
8:59
imugene officially announce their her-vaxx trial results
-
5:04
imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024